HMNC Brain Health is a clinical-stage neuroscience company developing more accessible therapies for difficult-to-treat depression including Treatment-Resistant Depression (TRD) and Major Depressive Disorder (MDD)..

By advancing targeted and accessible treatment options, HMNC aims to address significant unmet needs of millions of patients who are not helped sufficiently by existing mental health therapies. Our vision is to bring precision to psychiatry, paving the way for targeted, effective and accessible therapies.